PhuturdexDrug Pipeline Intelligence

Phuturdex › Listed companies

Companies listed in the US · updated 13 November 2026

Companies listed in the US

Data from official sources, not financial advice.

367 companies listed in the United States (exchange and ticker from SEC EDGAR) that sponsor active clinical trials, with their pipeline by phase, upcoming dates and SEC data, updated 13 November 2026.

Public preview

Preview: 367 listed companies. Sign up for free to search all 8,346 drugs and 30,697 trials, with filters, email alerts, PDF and Excel.

Get free access →

Companies with the most drugs in development

All companies (A–Z)

Sources: SEC EDGAR (exchange, ticker, filings and XBRL financial data, US Government works); ClinicalTrials.gov (U.S. National Library of Medicine), FDA (Drugs@FDA, Orange and Purple Book, orphan drugs) and EMA, data processed by Phuturdex and updated 13 November 2026. Active trials = recruiting or ongoing, phases I–III. The sponsor is the one stated by each trial; company names are linked to the SEC only when they are the same apart from the legal form. Patents, exclusivities, approvals and opinions are attributed to the company only when it holds them in the official register. No stock prices or charts. Only the official sources are authoritative.

ItalianoFrançaisDeutsch